# Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes

> **NCT05389631** · — · COMPLETED · sponsor: **Helios Health Institute GmbH** · enrollment: 76 (actual)

## Conditions studied

- Aortic Valve Disease

## Interventions

- **OTHER:** no intervention

## Key facts

- **NCT ID:** NCT05389631
- **Lead sponsor:** Helios Health Institute GmbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-17
- **Primary completion:** 2023-12-21
- **Final completion:** 2023-12-21
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-10-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05389631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05389631, "Trifecta and Epic ViV Detailed Insights Into Management Strategies and Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05389631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*